Emily Sabbagh
Oral and Maxillofacial Surgery · Auburn, WANPI 1154400596
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.9% of the total across 232 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 21.6% — the pattern of someone who eats at a lot of different presentations. Among oral and maxillofacial surgery clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 232 payments — averaging $43.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merz North America, Inc.$2K
- AstraZeneca$1K
- Novo Nordisk$953
- Lilly USA, LLC$853
- GSK$742
- Amgen$588
- plus $4K from 27 others
What the payments were for
- Speaking & faculty fees$10%
- Travel & lodging$8098%
- Food & beverage$9,19592%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merz North America, Inc. | 28 | $2,159 |
| AstraZeneca | 14 | $1,131 |
| Novo Nordisk | 31 | $953 |
| Lilly USA, LLC | 17 | $853 |
| GSK | 13 | $742 |
| Amgen | 13 | $588 |
| Biohaven Pharmaceuticals, Inc. | 10 | $525 |
| AbbVie | 14 | $351 |
| Corcept Therapeutics | 5 | $351 |
| Dexcom, Inc. | 3 | $303 |
| Galderma Laboratories, L.p. | 21 | $281 |
| Bayer | 11 | $236 |
| Johnson & Johnson | 6 | $206 |
| Daiichi Sankyo Inc. | 8 | $180 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $161 |
| Revance Therapeutics, Inc. | 4 | $126 |
| Radius Health, Inc. | 1 | $124 |
| Insulet Corporation | 1 | $118 |
| Kowa Pharmaceuticals America, Inc. | 4 | $95 |
| Phathom Pharmaceuticals, Inc. | 3 | $72 |
| Boehringer Ingelheim | 3 | $71 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $69 |
| Mylan Specialty L.p. | 3 | $51 |
| Amarin Pharma, Inc. | 3 | $50 |
| Axsome Therapeutics, Inc. | 1 | $27 |
| Ultragenyx Pharmaceutical Inc. | 1 | $26 |
| Pfizer | 1 | $26 |
| Abbott | 1 | $25 |
| Astellas Pharma US Inc | 1 | $24 |
| Neurocrine Biosciences, Inc. | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| Mayne Pharma Commercial LLC | 2 | $17 |
| Merck | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,005 in reported general payments places this provider in the 90th percentile of 206 oral and maxillofacial surgery providers in Washington.
See all oral and maxillofacial surgery providers in Washington →
Other oral and maxillofacial surgery in Auburn
- Kenji HiguchiSpokane Valley$75K
- Benjamin JohnsonRenton$62K
- Caitlin MagrawSeattle$45K
- Yu YehFederal Way$25K
- Guilermo ChaconPuyallup$16K
- Luis VegaIssaquah$14K
- Sukhdeep DhaliwalPoulsbo$14K
- Srinivasa ChandraSeattle$14K
- Dale BloomquistSeattle$12K
- Matthew EpsteinSeattle$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.